Paper283262
A human breast adenocarcinoma with chromosome and isoenzyme markers similar to those of the HeLa line.
Pathak S and 4 others. J Natl Cancer Inst, 1979. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. A human breast adenocarcinoma with chromosome and isoenzyme markers similar to those of the HeLa line. Papers, record 283262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/283262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Breast Neoplasms | Major topic |
| Chromosome Aberrations | Major topic |
| Chromosomes, Human, 1-3 | Major topic |
| HeLa Cells | Major topic |
| Isoenzymes | Major topic |
| Cell Line | |
| Female | |
| Glucosephosphate Dehydrogenase | |
| Humans | |
| Middle Aged | |
| Neoplasms, Experimental |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30363973 | Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines. | Int J Breast Cancer | 2018 | https://conductscience.org/library/papers/30363973 | PubMed |
| 28808525 | Anticancer metallohelices: nanomolar potency and high selectivity. | Chem Sci | 2016 | https://conductscience.org/library/papers/28808525 | PubMed |
| 27447733 | Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences. | J Proteome Res | 2016 | https://conductscience.org/library/papers/27447733 | PubMed |
| 24196532 | Do you know the sex of your cells? | Am J Physiol Cell Physiol | 2014 | https://conductscience.org/library/papers/24196532 | PubMed |
| 22859737 | Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer. | Exp Biol Med (Maywood) | 2012 | https://conductscience.org/library/papers/22859737 | PubMed |
| 6988327 | A molecular approach to the identification and individualization of human and animal cells in culture: isozyme and allozyme genetic signatures. | In Vitro | 1980 | https://conductscience.org/library/papers/6988327 | PubMed |
| 3978245 | Development of a new human breast cancer cell line Ia-270. | Breast Cancer Res Treat | 1985 | https://conductscience.org/library/papers/3978245 | PubMed |
| 3494191 | Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. | Mol Cell Biol | 1987 | https://conductscience.org/library/papers/3494191 | PubMed |
| 3308827 | Genetic predisposition to cancer with special reference to mutagen sensitivity. | In Vitro Cell Dev Biol | 1987 | https://conductscience.org/library/papers/3308827 | PubMed |
| 3185547 | Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. | Mol Cell Biol | 1988 | https://conductscience.org/library/papers/3185547 | PubMed |
| 2537620 | Activation of the Na+/H+ antiport is not required for epidermal growth factor-dependent gene expression, growth inhibition or proliferation in human breast cancer cells. | Biochem J | 1989 | https://conductscience.org/library/papers/2537620 | PubMed |
| 2182210 | Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity. | Cancer Metastasis Rev | 1990 | https://conductscience.org/library/papers/2182210 | PubMed |
| 730202 | Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. | In Vitro | 1978 | https://conductscience.org/library/papers/730202 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/283262
GET https://conductscience.org/api/papers/v1/283262/authors